BFA
LOXO

BlackRock Fund Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

BlackRock Fund Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23.2M Buy
722,972
+354,533
+96% +$9.09M ﹤0.01% 2097
2016
Q3 		$9.65M Buy
368,439
+23,483
+7% +$614K ﹤0.01% 2493
2016
Q2 		$8M Buy
344,956
+112,210
+48% +$2.79M ﹤0.01% 2534
2016
Q1 		$6.36M Sell
232,746
-5,033
-2% -$105K ﹤0.01% 2616
2015
Q4 		$6.76M Buy
237,779
+42,918
+22% +$1.15M ﹤0.01% 2672
2015
Q3 		$3.41M Sell
194,861
-2,409
-1% -$47.1K ﹤0.01% 2975
2015
Q2 		$3.56M Buy
197,270
+93,458
+90% +$1.28M ﹤0.01% 3054
2015
Q1 		$1.29M Buy
103,812
+6,906
+7% +$86K ﹤0.01% 3194
2014
Q4 		$1.14M Buy
96,906
+16,587
+21% +$193K ﹤0.01% 3217
2014
Q3 		$1.05M Buy
+80,319
New +$1.04M ﹤0.01% 3194

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BlackRock Fund Advisors's LOXO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Loxo Oncology, Inc (LOXO) stake by 96% in Q4 2016, buying an estimated $9.09M and bringing the position to 722,972 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

BlackRock Fund Advisors first reported a position in LOXO in Q3 2014 and has held it in 10 quarters since. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • BlackRock Fund Advisors held 722,972 shares of Loxo Oncology, Inc worth $23.2M as of Q4 2016.
  • BlackRock Fund Advisors bought 354,533 Loxo Oncology, Inc shares in Q4 2016, an estimated $9.09M.
  • Loxo Oncology, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2097 holding.
  • BlackRock Fund Advisors first reported a position in Loxo Oncology, Inc in Q3 2014 and has held it in 10 quarters since.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.